More congressional interest in generic drugs
Executive Summary
Consumer Interests Subcommittee of the House Select Committee on Aging has scheduled a March 1 hearing on the generic scandal. Chaired by Rep. Lloyd (D-Tenn.), the panel hopes to present "an accurate and balanced record" of the safety and efficacy of generics, according to staff. Witnesses are expected to include representatives of FDA and professional and trade associations.